多组学技术及其在肝细胞癌中的临床应用：当前进展与未来机遇

杨万水; 蒋涵羽; 刘超; 魏靖伟; 周宇; 宫鹏云; 宋彬; 田捷

doi:10.24920/003984

Your Location：

Home >

Browse articles >

多组学技术及其在肝细胞癌中的临床应用：当前进展与未来机遇

中国医学科学杂志（英文版） 2021年36卷第3期页码：173-186

综述 | Updated：2024-04-10

- 多组学技术及其在肝细胞癌中的临床应用：当前进展与未来机遇
- Affiliations：
  
  1. 1Department of Nutrition, School of Public Health, Anhui Medical University, Hefei 230032, China
  2. 2Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China
  3. 3Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine and Engineering, Beihang University, Beijing 100191, China
  4. 4Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology, Beijing 100191, China
  5. 5Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China
  6. 6Beijing Key Laboratory of Molecular Imaging, Beijing 100190, China
  7. 7University of Chinese Academy of Sciences, Beijing 100049, China
  8. 8School of Life Science and Technology, Xidian University, Xi’an 710126, China
  9. 9Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education, School of Life Science and Technology, Xidian University, Xi’an 710126, China
- Author bio：
  
  *E-mail: Bin Song, anicesong@vip.sina.com;
- Funds：
- DOI：10.24920/003984
  中图分类号：
- 收稿日期：2021-08-16，
  
  录用日期：2021-9-14，
  
  网络出版日期：2021-09-17，
  
  纸质出版日期：2021-09-17
- Accepted：
Scan QR Code
杨万水, 蒋涵羽, 刘超, 等. 多组学技术及其在肝细胞癌中的临床应用：当前进展与未来机遇[J]. 中国医学科学杂志（英文版）, 2021,36(3):173-186.

Yang Wanshui, Jiang Hanyu, Liu Chao, et al. Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities[J]. Chinese medical sciences journal, 2021, 36(3): 173-186.
杨万水, 蒋涵羽, 刘超, 等. 多组学技术及其在肝细胞癌中的临床应用：当前进展与未来机遇[J]. 中国医学科学杂志（英文版）, 2021,36(3):173-186. DOI： 10.24920/003984.

Yang Wanshui, Jiang Hanyu, Liu Chao, et al. Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities[J]. Chinese medical sciences journal, 2021, 36(3): 173-186. DOI： 10.24920/003984.

摘要

全球范围内

肝细胞癌(Hepatocellular carcinoma

HCC)是第六大常见恶性肿瘤

也是癌症相关死亡的第四大原因。中国HCC病例占全球病例的50%以上

导致HCC成为重要的公共卫生问题。尽管HCC诊断和治疗取得了进步

但高复发率仍然是HCC治愈的主要障碍。目前

多组学技术的融合促进了临床上疾病的监测、精准诊断和个体化治疗。无创的影像组学利用术前影像图像反映特定临床结局相关的细微像素级的模式变化。影像组学已广泛应用于预测组织病理学诊断、评估治疗反应和预测疾病预后。高通量测序技术和基因表达谱分析使基因组学和蛋白质组学能够识别HCC中不同的转录组亚型和反复性的遗传改变

这将揭示病理生理学上复杂的疾病发生过程。医学大数据的积累和人工智能技术的发展使我们更好地从多组学的角度深入理解HCC的发病机制

并显示出将HCC的外科治疗或介入治疗转化为抗肿瘤发生机制治疗的潜力

这将极大地推动HCC精准诊疗的发展。

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the fourth leading cause of cancer related death worldwide. China covers over half of cases

leading HCC to be a vital threaten to public health. Despite advances in diagnosis and treatments

high recurrence rate remains a major obstacle in HCC management. Multi-omics currently facilitates surveillance

precise diagnosis

and personalized treatment decision making in clinical setting. Non-invasive radiomics utilizes preoperative radiological imaging to reflect subtle pixel-level pattern changes that correlate to specific clinical outcomes. Radiomics has been widely used in histopathological diagnosis prediction

treatment response evaluation

and prognosis prediction. High-throughput sequencing and gene expression profiling enabled genomics and proteomics to identify distinct transcriptomic subclasses and recurrent genetic alterations in HCC

which would reveal the complex multistep process of the pathophysiology. The accumulation of big medical data and the development of artificial intelligence techniques are providing new insights for our better understanding of the mechanism of HCC via multi-omics

and show potential to convert surgical/intervention treatment into an antitumorigenic one

which would greatly advance precision medicine in HCC management.

关键词

Keywords

references

Llovet JM , Zucman-Rossi J , Pikarsky E , et al . Hepatocellular carcinoma . Nat Rev Dis Primers 2016 ; 2 : 16018 . doi: 10.1038/nrdp.2016.18 1001-9294-36-3-173/nrdp.2016.18 . DOI: 10.1038/nrdp.2016.18 http://doi.org/10.1038/nrdp.2016.18

McGlynn KA , Petrick JL , London WT . Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability . Clin Liver Dis 2015 ; 19 ( 2 ): 223 - 38 . doi: 10.1016/j.cld.2015.01.001 1001-9294-36-3-173/j.cld.2015.01.001 . DOI: 10.1016/j.cld.2015.01.001 http://doi.org/10.1016/j.cld.2015.01.001

International Agency for Research on Cancer. GLOBOCAN 2018 . Estimated age-standardized incidence rates (World) in 2020, liver, both sexes, all ages . Available from https://gco.iarc.fr/today/online-analysis-map?v=2020 & mode=population & mode_population=continents & population=900 & populations=900 & key=asr & sex=0 & cancer=11 & type=0 & statistic=5 & prevalence=0 & population_groupearth & color_palette=default & map_scale=quantile & map_nb_colors=5 & continent=0 & rotate=%255B10%252C0%255D ( 2020 ). Accessed August 16, 2021. https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=11&type=0&statistic=5&prevalence=0&population_groupearth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&rotate=%255B10%252C0%255D https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=11&type=0&statistic=5&prevalence=0&population_groupearth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&rotate=%255B10%252C0%255D

Tabrizian P , Jibara G , Shrager B , et al . Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis . Ann Surg 2015 ; 261 ( 5 ): 947 - 55 . doi: 10.1097/SLA.0000000000000710 1001-9294-36-3-173/SLA.0000000000000710 . DOI: 10.1097/SLA.0000000000000710 http://doi.org/10.1097/SLA.0000000000000710

Marrero JA , Kulik LM , Sirlin CB , et al . Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases . Hepatology 2018 ; 68 ( 2 ): 723 - 50 . doi: 10.1002/hep.29913 1001-9294-36-3-173/hep.29913 . DOI: 10.1002/hep.29913 http://doi.org/10.1002/hep.29913

Lambin P , Leijenaar RTH , Deist TM , et al . Radiomics: the bridge between medical imaging and personalized medicine . Nat Rev Clin Oncol 2017 ; 14 ( 12 ): 749 - 62 . doi: 10.1038/nrclinonc.2017.141 1001-9294-36-3-173/nrclinonc.2017.141 . DOI: 10.1038/nrclinonc.2017.141 http://doi.org/10.1038/nrclinonc.2017.141

Wei J , Jiang H , Gu D , et al . Radiomics in liver diseases: Current progress and future opportunities . Liver Int 2020 ; 40 ( 9 ): 2050 - 63 . doi: 10.1111/liv.14555 1001-9294-36-3-173/liv.14555 . DOI: 10.1111/liv.14555 http://doi.org/10.1111/liv.14555

Zhou Y , He L , Huang Y , et al . CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma . Abdom Radiol (NY) 2017 ; 42 ( 6 ): 1695 - 704 . doi: 10.1007/s00261-017-1072-0 1001-9294-36-3-173/s00261-017-1072-0 . DOI: 10.1007/s00261-017-1072-0 http://doi.org/10.1007/s00261-017-1072-0

Cozzi L , Dinapoli N , Fogliata A , et al . Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy . BMC Cancer 2017 ; 17 ( 1 ): 829 . doi: 10.1186/s12885-017-3847-7 1001-9294-36-3-173/s12885-017-3847-7 . DOI: 10.1186/s12885-017-3847-7 http://doi.org/10.1186/s12885-017-3847-7

Naganawa S , Enooku K , Tateishi R , et al . Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis . Eur Radiol 2018 ; 28 ( 7 ): 3050 - 8 . doi: 10.1007/s00330-017-5270-5 1001-9294-36-3-173/s00330-017-5270-5 . DOI: 10.1007/s00330-017-5270-5 http://doi.org/10.1007/s00330-017-5270-5

Kew MC . Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis . Liver Int 2003 ; 23 ( 6 ): 405 - 9 . doi: 10.1111/j.1478-3231.2003.00869.x 1001-9294-36-3-173/j.1478-3231.2003.00869.x . DOI: 10.1111/j.1478-3231.2003.00869.x http://doi.org/10.1111/j.1478-3231.2003.00869.x

Seehawer M , Heinzmann F , D’Artista L, et al. Necroptosis microenvironment directs lineage commitment in liver cancer . Nature 2018 ; 562 ( 7725 ): 69 - 75 . doi: 10.1038/s41586-018-0519-y. Erratum in Nature 2018 1001-9294-36-3-173/s41586-018-0519-y. Erratum in Nature 2018 ; 564(7735):E9. doi 10.1038/s41586-018-0723-9 1001-9294-36-3-173/s41586-018-0723-9 . DOI: 10.1038/s41586-018-0723-9 http://doi.org/10.1038/s41586-018-0723-9

Yuan D , Huang S , Berger E , et al . Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell 2017 ; 31(6):771- 89 . e6 . doi: 10.1016/j.ccell.2017.05.006 1001-9294-36-3-173/j.ccell.2017.05.006 . DOI: 10.1016/j.ccell.2017.05.006 http://doi.org/10.1016/j.ccell.2017.05.006

Sia D , Villanueva A , Friedman SL , et al . Liver cancer cell of origin, molecular class, and effects on patient prognosis . Gastroenterology 2017 ; 152 ( 4 ): 745 - 61 . doi: 10.1053/j.gastro.2016.11.048 1001-9294-36-3-173/j.gastro.2016.11.048 . DOI: 10.1053/j.gastro.2016.11.048 http://doi.org/10.1053/j.gastro.2016.11.048

Li Z , Mao Y , Huang W , et al . Texture-based classification of different single liver lesion based on SPAIR T2W MRI images . BMC Med Imaging 2017 ; 17 ( 1 ): 42 . doi: 10.1186/s12880-017-0212-x 1001-9294-36-3-173/s12880-017-0212-x . DOI: 10.1186/s12880-017-0212-x http://doi.org/10.1186/s12880-017-0212-x

Trivizakis E , Manikis GC , Nikiforaki K , et al . Extending 2-D convolutional neural networks to 3-D for advancing deep learning cancer classification with application to MRI liver uumor differentiation . IEEE J Biomed Health Inform 2019 ; 23 ( 3 ): 923 - 30 . doi: 10.1109/JBHI.2018.2886276 1001-9294-36-3-173/JBHI.2018.2886276 . DOI: 10.1109/JBHI.2018.2886276 http://doi.org/10.1109/JBHI.2018.2886276

Jiang H , Liu X , Chen J , et al . Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma . Cancer Imaging 2019 ; 19 ( 1 ): 84 . doi: 10.1186/s40644-019-0266-9 1001-9294-36-3-173/s40644-019-0266-9 . DOI: 10.1186/s40644-019-0266-9 http://doi.org/10.1186/s40644-019-0266-9

Yao Z , Dong Y , Wu G , et al . Preoperative diagnosis and prediction of hepatocellular carcinoma: radiomics analysis based on multi-modal ultrasound images . BMC Cancer 2018 ; 18 ( 1 ): 1089 . doi: 10.1186/s12885-018-5003-4 1001-9294-36-3-173/s12885-018-5003-4 . DOI: 10.1186/s12885-018-5003-4 http://doi.org/10.1186/s12885-018-5003-4

Cucchetti A , Piscaglia F , Grigioni AD , et al . Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study . J Hepatol 2010 ; 52 ( 6 ): 880 - 8 . doi: 10.1016/j.jhep.2009.12.037 1001-9294-36-3-173/j.jhep.2009.12.037 . DOI: 10.1016/j.jhep.2009.12.037 http://doi.org/10.1016/j.jhep.2009.12.037

Zhou W , Zhang L , Wang K , et al . Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images . J Magn Reson Imaging 2017 ; 45 ( 5 ): 1476 - 84 . doi: 10.1002/jmri.25454 1001-9294-36-3-173/jmri.25454 . DOI: 10.1002/jmri.25454 http://doi.org/10.1002/jmri.25454

Wu M , Tan H , Gao F , et al . Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature . Eur Radiol 2019 ; 29 ( 6 ): 2802 - 11 . doi: 10.1007/s00330-018-5787-2 1001-9294-36-3-173/s00330-018-5787-2 . DOI: 10.1007/s00330-018-5787-2 http://doi.org/10.1007/s00330-018-5787-2

Ye Z , Jiang H , Chen J , et al . Texture analysis on

gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: a prospective study . Chin J Cancer Res 2019 ; 31 ( 5 ): 806 - 17 . doi: 10.21147/j.issn.1000-9604.2019.05.10 1001-9294-36-3-173/j.issn.1000-9604.2019.05.10 . DOI: 10.21147/j.issn.1000-9604.2019.05.10 http://doi.org/10.21147/j.issn.1000-9604.2019.05.10

Wei J , Jiang H , Zeng M , et al . Prediction of microvascular invasion in hepatocellular carcinoma via deep learning: a multi-center and prospective validation study . Cancers (Basel) 2021 ; 13 ( 10 ): 2368 . doi: 10.3390/cancers13102368 1001-9294-36-3-173/cancers13102368 . DOI: 10.3390/cancers13102368 http://doi.org/10.3390/cancers13102368

Xu X , Zhang HL , Liu QP , et al . Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma . J Hepatol 2019 ; 70 ( 6 ): 1133 - 44 . doi: 10.1016/j.jhep.2019.02.023 1001-9294-36-3-173/j.jhep.2019.02.023 . DOI: 10.1016/j.jhep.2019.02.023 http://doi.org/10.1016/j.jhep.2019.02.023

Banerjee S , Wang DS , Kim HJ , et al . A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma . Hepatology 2015 ; 62 ( 3 ): 792 - 800 . doi: 10.1002/hep.27877 1001-9294-36-3-173/hep.27877 . DOI: 10.1002/hep.27877 http://doi.org/10.1002/hep.27877

Sun R , Limkin EJ , Vakalopoulou M , et al . A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study . Lancet Oncol 2018 ; 19 ( 9 ): 1180 - 91 . doi: 10.1016/S1470-2045(18)30413-3 1001-9294-36-3-173/S1470-2045(18)30413-3 . DOI: 10.1016/S1470-2045(18)30413-3 http://doi.org/10.1016/S1470-2045(18)30413-3

Chen S , Feng S , Wei J , et al . Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging . Eur Radiol 2019 ; 29 ( 8 ): 4177 - 87 . doi: 10.1007/s00330-018-5986-x 1001-9294-36-3-173/s00330-018-5986-x . DOI: 10.1007/s00330-018-5986-x http://doi.org/10.1007/s00330-018-5986-x

Hectors SJ , Lewis S , Besa C , et al . MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma . Eur Radiol 2020 ; 30 ( 7 ): 3759 - 69 . doi: 10.1007/s00330-020-06675-2 1001-9294-36-3-173/s00330-020-06675-2 . DOI: 10.1007/s00330-020-06675-2 http://doi.org/10.1007/s00330-020-06675-2

Yuan C , Wang Z , Gu D , et al . Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a radiomics nomogram . Cancer Imaging 2019 ; 19 ( 1 ): 21 . doi: 10.1186/s40644-019-0207-7 1001-9294-36-3-173/s40644-019-0207-7 . DOI: 10.1186/s40644-019-0207-7 http://doi.org/10.1186/s40644-019-0207-7

Ji GW , Zhu FP , Xu Q , et al . Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study . Radiology 2020 ; 294 ( 3 ): 568 - 79 . doi: 10.1148/radiol.2020191470 1001-9294-36-3-173/radiol.2020191470 . DOI: 10.1148/radiol.2020191470 http://doi.org/10.1148/radiol.2020191470

Hui TCH , Chuah TK , Low HM , et al . Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study. Clin Radiol 2018 ; 73(12):1056 . e11- 1056 . e16 . doi: 10.1016/j.crad.2018.07.109 1001-9294-36-3-173/j.crad.2018.07.109 . DOI: 10.1016/j.crad.2018.07.109 http://doi.org/10.1016/j.crad.2018.07.109

Park HJ , Kim JH , Choi SY , et al . Prediction of therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization based on pretherapeutic dynamic CT and textural findings . AJR Am J Roentgenol 2017 ; 209 ( 4 ): w211 - w220 . doi: 10.2214/AJR.16.17398 1001-9294-36-3-173/AJR.16.17398 . DOI: 10.2214/AJR.16.17398 http://doi.org/10.2214/AJR.16.17398

Kim J , Choi SJ , Lee SH , et al . Predicting survival using pretreatment CT for patients with hepatocellular carcinoma treated with transarterial chemoembolization: comparison of models using radiomics . AJR Am J Roentgenol 2018 ; 211 ( 5 ): 1026 - 34 . doi: 10.2214/AJR.18.19507 1001-9294-36-3-173/AJR.18.19507 . DOI: 10.2214/AJR.18.19507 http://doi.org/10.2214/AJR.18.19507

Blanc-Durand P , van der Gucht A , Jreige M , et al . Signature of survival: a 18 F-FDG PET based whole-liver radiomic analysis predicts survival after 90 Y-TARE for hepatocellular carcinoma . Oncotarget 2017 ; 9 ( 4 ): 4549 - 58 . doi: 10.18632/oncotarget.23423 1001-9294-36-3-173/oncotarget.23423 . DOI: 10.18632/oncotarget.23423 http://doi.org/10.18632/oncotarget.23423

Mulé S , Thiefin G , Costentin C , et al . Advanced hepatocellular carcinoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with sorafenib . Radiology 2018 ; 288 ( 2 ): 445 - 55 . doi: 10.1148/radiol.2018171320 1001-9294-36-3-173/radiol.2018171320 . DOI: 10.1148/radiol.2018171320 http://doi.org/10.1148/radiol.2018171320

Llovet JM , Kelley RK , Villanueva A , et al . Hepatocellular carcinoma . Nat Rev Dis Primers 2021 ; 7 ( 1 ): 6 . doi: 10.1038/s41572-020-00240-3 1001-9294-36-3-173/s41572-020-00240-3 . DOI: 10.1038/s41572-020-00240-3 http://doi.org/10.1038/s41572-020-00240-3

Calderaro J , Ziol M , Paradis V , et al . Molecular and histological correlations in liver cancer . J Hepatol 2019 ; 71 ( 3 ): 616 - 30 . doi: 10.1016/j.jhep.2019.06.001 1001-9294-36-3-173/j.jhep.2019.06.001 . DOI: 10.1016/j.jhep.2019.06.001 http://doi.org/10.1016/j.jhep.2019.06.001

Zucman-Rossi J , Villanueva A , Nault JC , et al . Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 2015 ; 149(5):1226- 39 . e4 . doi: 10.1053/j.gastro.2015.05.061 1001-9294-36-3-173/j.gastro.2015.05.061 . DOI: 10.1053/j.gastro.2015.05.061 http://doi.org/10.1053/j.gastro.2015.05.061

Totoki Y , Tatsuno K , Covington KR , et al . Trans-ancestry mutational landscape of hepatocellular carcinoma genomes . Nat Genet 2014 ; 46 ( 12 ): 1267 - 73 . doi: 10.1038/ng.3126 1001-9294-36-3-173/ng.3126 . DOI: 10.1038/ng.3126 http://doi.org/10.1038/ng.3126

Ahn SM , Jang SJ , Shim JH , et al . Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification . Hepatology 2014 ; 60 ( 6 ): 1972 - 82 . doi: 10.1002/hep.27198 1001-9294-36-3-173/hep.27198 . DOI: 10.1002/hep.27198 http://doi.org/10.1002/hep.27198

Schulze K , Imbeaud S , Letouzé E , et al . Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets . Nat Genet 2015 ; 47 ( 5 ): 505 - 11 . doi: 10.1038/ng.3252 1001-9294-36-3-173/ng.3252 . DOI: 10.1038/ng.3252 http://doi.org/10.1038/ng.3252

Guichard C , Amaddeo G , Imbeaud S , et al . Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma . Nat Genet 2012 ; 44 ( 6 ): 694 - 8 . doi: 10.1038/ng.2256 1001-9294-36-3-173/ng.2256 . DOI: 10.1038/ng.2256 http://doi.org/10.1038/ng.2256

Nault JC , Mallet M , Pilati C , et al . High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions . Nat Commun 2013 ; 4 : 2218 . doi: 10.1038/ncomms3218. Erratum in Nat Commun 2013 1001-9294-36-3-173/ncomms3218. Erratum in Nat Commun 2013 ; 4:2577. doi 10.1038/ncomms3577 1001-9294-36-3-173/ncomms3577 . DOI: 10.1038/ncomms3577 http://doi.org/10.1038/ncomms3577

Paterlini-Bréchot P , Saigo K , Murakami Y , et al . Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene . Oncogene 2003 ; 22 ( 25 ): 3911 - 6 . doi: 10.1038/sj.onc.1206492 1001-9294-36-3-173/sj.onc.1206492 . DOI: 10.1038/sj.onc.1206492 http://doi.org/10.1038/sj.onc.1206492

Bayard Q , Meunier L , Peneau C , et al . Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress . Nat Commun 2018 ; 9 ( 1 ): 5235 . doi: 10.1038/s41467-018-07552-9 1001-9294-36-3-173/s41467-018-07552-9 . DOI: 10.1038/s41467-018-07552-9 http://doi.org/10.1038/s41467-018-07552-9

Chiang DY , Villanueva A , Hoshida Y , et al . Focal gains of VEGFA and molecular classification of hepatocellular carcinoma . Cancer Res 2008 ; 68 ( 16 ): 6779 - 88 . doi: 10.1158/0008-5472.CAN-08-0742 1001-9294-36-3-173/0008-5472.CAN-08-0742 . DOI: 10.1158/0008-5472.CAN-08-0742 http://doi.org/10.1158/0008-5472.CAN-08-0742

Bressac B , Kew M , Wands J , et al . Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa . Nature 1991 ; 350 ( 6317 ): 429 - 31 . doi: 10.1038/350429a0 1001-9294-36-3-173/350429a0 . DOI: 10.1038/350429a0 http://doi.org/10.1038/350429a0

Wang B , Huang G , Wang D , et al . Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis . J Hepatol 2010 ; 53 ( 3 ): 508 - 18 . doi: 10.1016/j.jhep.2010.03.026 1001-9294-36-3-173/j.jhep.2010.03.026 . DOI: 10.1016/j.jhep.2010.03.026 http://doi.org/10.1016/j.jhep.2010.03.026

Romeo S , Kozlitina J , Xing C , et al . Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease . Nat Genet 2008 ; 40 ( 12 ): 1461 - 5 . doi: 10.1038/ng.257 1001-9294-36-3-173/ng.257 . DOI: 10.1038/ng.257 http://doi.org/10.1038/ng.257

Buch S , Stickel F , Trépo E , et al . A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis . Nat Genet 2015 ; 47 ( 12 ): 1443 - 8 . doi: 10.1038/ng.3417 1001-9294-36-3-173/ng.3417 . DOI: 10.1038/ng.3417 http://doi.org/10.1038/ng.3417

Rebouissou S , Nault JC . Advances in molecular classification and precision oncology in hepatocellular carcinoma . J Hepatol 2020 ; 72 ( 2 ): 215 - 29 . doi: 10.1016/j.jhep.2019.08.017 1001-9294-36-3-173/j.jhep.2019.08.017 . DOI: 10.1016/j.jhep.2019.08.017 http://doi.org/10.1016/j.jhep.2019.08.017

Hoshida Y , Nijman SM , Kobayashi M , et al . Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma . Cancer Res 2009 ; 69 ( 18 ): 7385 - 92 . doi: 10.1158/0008-5472.CAN-09-1089 1001-9294-36-3-173/0008-5472.CAN-09-1089 . DOI: 10.1158/0008-5472.CAN-09-1089 http://doi.org/10.1158/0008-5472.CAN-09-1089

Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 2017 ; 169(7):1327- 41 . e23 . doi: 10.1016/j.cell.2017.05.046 1001-9294-36-3-173/j.cell.2017.05.046 . DOI: 10.1016/j.cell.2017.05.046 http://doi.org/10.1016/j.cell.2017.05.046

Lee JS , Heo J , Libbrecht L , et al . A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells . Nat Med 2006 ; 12 ( 4 ): 410 - 6 . doi: 10.1038/nm1377 1001-9294-36-3-173/nm1377 . DOI: 10.1038/nm1377 http://doi.org/10.1038/nm1377

Boyault S , Rickman DS, de Reyniès A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets . Hepatology 2007 ; 45 ( 1 ): 42 - 52 . doi: 10.1002/hep.21467 1001-9294-36-3-173/hep.21467 . DOI: 10.1002/hep.21467 http://doi.org/10.1002/hep.21467

Sia D , Jiao Y , Martinez-Quetglas I , et al . Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features . Gastroenterology 2017 ; 153 ( 3 ): 812 - 26 . doi: 10.1053/j.gastro.2017.06.007 1001-9294-36-3-173/j.gastro.2017.06.007 . DOI: 10.1053/j.gastro.2017.06.007 http://doi.org/10.1053/j.gastro.2017.06.007

Llovet JM , Montal R , Sia D , et al . Molecular therapies and precision medicine for hepatocellular carcinoma . Nat Rev Clin Oncol 2018 ; 15 ( 10 ): 599 - 616 . doi: 10.1038/s41571-018-0073-4 1001-9294-36-3-173/s41571-018-0073-4 . DOI: 10.1038/s41571-018-0073-4 http://doi.org/10.1038/s41571-018-0073-4

Erstad DJ , Fuchs BC , Tanabe KK . Molecular signatures in hepatocellular carcinoma: a step toward rationally designed cancer therapy . Cancer 2018 ; 124 ( 15 ): 3084 - 104 . doi: 10.1002/cncr.31257 1001-9294-36-3-173/cncr.31257 . DOI: 10.1002/cncr.31257 http://doi.org/10.1002/cncr.31257

Lee JS , Chu IS , Heo J , et al . Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling . Hepatology 2004 ; 40 ( 3 ): 667 - 76 . doi: 10.1002/hep.20375 1001-9294-36-3-173/hep.20375 . DOI: 10.1002/hep.20375 http://doi.org/10.1002/hep.20375

Calderaro J , Couchy G , Imbeaud S , et al . Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification . J Hepatol 2017 ; 67 ( 4 ): 727 - 38 . doi: 10.1016/j.jhep.2017.05.014 1001-9294-36-3-173/j.jhep.2017.05.014 . DOI: 10.1016/j.jhep.2017.05.014 http://doi.org/10.1016/j.jhep.2017.05.014

Lachenmayer A , Alsinet C , Savic R , et al . Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib . Clin Cancer Res 2012 ; 18 ( 18 ): 4997 - 5007 . doi: 10.1158/1078-0432.CCR-11-2322 1001-9294-36-3-173/1078-0432.CCR-11-2322 . DOI: 10.1158/1078-0432.CCR-11-2322 http://doi.org/10.1158/1078-0432.CCR-11-2322

Ruiz de Galarreta M , Bresnahan E , Molina-Sánchez P , et al . β-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma . Cancer Discov 2019 ; 9 ( 8 ): 1124 - 41 . doi: 10.1158/2159-8290.CD-19-0074 1001-9294-36-3-173/2159-8290.CD-19-0074 . DOI: 10.1158/2159-8290.CD-19-0074 http://doi.org/10.1158/2159-8290.CD-19-0074

Takayasu K , Arii S , Ikai I , et al . Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients . Gastroenterology 2006 ; 131 ( 2 ): 461 - 9 . doi: 10.1053/j.gastro.2006.05.021 1001-9294-36-3-173/j.gastro.2006.05.021 . DOI: 10.1053/j.gastro.2006.05.021 http://doi.org/10.1053/j.gastro.2006.05.021

Lazcano G , Papuzinski C , Madrid E , et al . General concepts in biostatistics and clinical epidemiology: observational studies with cohort design. Medwave 2019 ; 19(11):e7748. Spanish and English. doi: 10.5867/medwave.2019.11.7748 1001-9294-36-3-173/medwave.2019.11.7748 . DOI: 10.5867/medwave.2019.11.7748 http://doi.org/10.5867/medwave.2019.11.7748

Kim S , Shin J , Kim DY , et al . Radiomics on Gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma . Clin Cancer Res 2019 ; 25 ( 13 ): 3847 - 55 . doi: 10.1158/1078-0432.CCR-18-2861 1001-9294-36-3-173/1078-0432.CCR-18-2861 . DOI: 10.1158/1078-0432.CCR-18-2861 http://doi.org/10.1158/1078-0432.CCR-18-2861

Grimes DA , Schulz KF . Cohort studies: marching towards outcomes . Lancet 2002 ; 359 ( 9303 ): 341 - 5 . doi: 10.1016/S0140-6736(02)07500-1 1001-9294-36-3-173/S0140-6736(02)07500-1 . DOI: 10.1016/S0140-6736(02)07500-1 http://doi.org/10.1016/S0140-6736(02)07500-1

Font C , Carmona-Bayonas A , Beato C , et al . Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study . Eur Respir J 2017 ; 49 ( 1 ): 1600282 . doi: 10.1183/13993003.00282-2016 1001-9294-36-3-173/13993003.00282-2016 . DOI: 10.1183/13993003.00282-2016 http://doi.org/10.1183/13993003.00282-2016

Liu L , Nevo D , Nishihara R , et al . Utility of inverse probability weighting in molecular pathological epidemiology . Eur J Epidemiol 2018 ; 33 ( 4 ): 381 - 92 . doi: 10.1007/s10654-017-0346-8 1001-9294-36-3-173/s10654-017-0346-8 . DOI: 10.1007/s10654-017-0346-8 http://doi.org/10.1007/s10654-017-0346-8

Dettori JR . Loss to follow-up . Evid Based Spine Care J 2011 ; 2 ( 1 ): 7 - 10 . doi: 10.1055/s-0030-1267080 1001-9294-36-3-173/s-0030-1267080 . DOI: 10.1055/s-0030-1267080 http://doi.org/10.1055/s-0030-1267080

Ferreira JC , Patino CM . Loss to follow-up and missing data: important issues that can affect your study results . J Bras Pneumol 2019 ; 45 ( 2 ): e20190091 . doi: 10.1590/1806-3713/e20190091 1001-9294-36-3-173/1806-3713/e20190091 . DOI: 10.1590/1806-3713/e20190091 http://doi.org/10.1590/1806-3713/e20190091

Ogino S , Chan AT , Fuchs CS , et al . Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field . Gut 2011 ; 60 ( 3 ): 397 - 411 . doi: 10.1136/gut.2010.217182 1001-9294-36-3-173/gut.2010.217182 . DOI: 10.1136/gut.2010.217182 http://doi.org/10.1136/gut.2010.217182

López de Maturana E , Alonso L , Alarcón P , et al . Challenges in the integration of omics and non-omics data . Genes (Basel) 2019 ; 10 ( 3 ): 238 . doi: 10.3390/genes10030238 1001-9294-36-3-173/genes10030238 . DOI: 10.3390/genes10030238 http://doi.org/10.3390/genes10030238

López de Maturana E , Pineda S , Brand A , et al . Toward the integration of Omics data in epidemiological studies: still a “long and winding road” . Genet Epidemiol 2016 ; 40 ( 7 ): 558 - 69 . doi: 10.1002/gepi.21992 1001-9294-36-3-173/gepi.21992 . DOI: 10.1002/gepi.21992 http://doi.org/10.1002/gepi.21992

Lehmann TM , Gönner C , Spitzer K . Survey: interpolation methods in medical image processing . IEEE Trans Med Imaging 1999 ; 18 ( 11 ): 1049 - 75 . doi: 10.1109/42.816070 1001-9294-36-3-173/42.816070 . DOI: 10.1109/42.816070 http://doi.org/10.1109/42.816070

Lehmann T , Oberschelp W , Pelikan E , et al . Bildverarbeitung für die Medizin: Grundlagen, Modelle, Methoden, Anwendungen . Berlin, Heidelberg: Springer-Verlag ; 2013 . German. doi: 10.1007/978-3-642-60487-4 1001-9294-36-3-173/978-3-642-60487-4 . DOI: 10.1007/978-3-642-60487-4 http://doi.org/10.1007/978-3-642-60487-4

Yang Q , Wei J , Hao X , et al . Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: a multicentre study . EBioMedicine 2020 ; 56 : 102777 . doi: 10.1016/j.ebiom.2020.102777 1001-9294-36-3-173/j.ebiom.2020.102777 . DOI: 10.1016/j.ebiom.2020.102777 http://doi.org/10.1016/j.ebiom.2020.102777

Zhao M , Zhang Z , Chow TWS . Trace ratio criterion based generalized discriminative learning for semi-supervised dimensionality reduction . Pattern Recognit 2012 ; 45 ( 4 ): 1482 - 99 . doi: 10.1016/j.patcog.2011.10.008 1001-9294-36-3-173/j.patcog.2011.10.008 . DOI: 10.1016/j.patcog.2011.10.008 http://doi.org/10.1016/j.patcog.2011.10.008

Zhao Z , Liu H . Spectral feature selection for supervised and unsupervised learning. ICML 2007: Proceedings of the 24th international conference on machine learning . June 20-24, 2007; Corvalis Oregon, USA . Vol. 227 . p. 1151 - 1157 . doi: 10.1145/1273496.1273641 1001-9294-36-3-173/1273496.1273641 . DOI: 10.1145/1273496.1273641 http://doi.org/10.1145/1273496.1273641

Nie F , Huang H , Cai X , et al. Efficient and robust feature selection via Joint _2, 1-Norms Minimization. In: NIPS 2010: Proceedings of the 23rd International Conference on Neural Information Processing Systems . December 6-11, 2010; Vancouver, Cananda. Vol 2 .p. 1813 - 1821 .

Cai D , Zhang C , He X . Unsupervised Feature Selection for Multi-Cluster Data. Proceedings of the 16th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. KDD 2010. July 25-28, 2010; Washington DC , USA. 2010 . p. 333 - 342 . doi: 10.1145/1835804.1835848 1001-9294-36-3-173/1835804.1835848 . DOI: 10.1145/1835804.1835848 http://doi.org/10.1145/1835804.1835848

Zhang P , Feng J , Wu X , et al . Bioinformatics analysis of candidate genes and pathways related to hepatocellular carcinoma in China: a study based on public databases . Pathol Oncol Res 2021 ; 27 : 588532 . doi: 10.3389/pore.2021.588532 1001-9294-36-3-173/pore.2021.588532 . DOI: 10.3389/pore.2021.588532 http://doi.org/10.3389/pore.2021.588532

Zhou X , Shi M , Cao J , et al . S100 calcium binding protein A10, a novel oncogene, promotes the proliferation, invasion, and migration of hepatocellular carcinoma . Front Genet 2021 ; 12 : 695036 . doi: 10.3389/fgene.2021.695036 1001-9294-36-3-173/fgene.2021.695036 . DOI: 10.3389/fgene.2021.695036 http://doi.org/10.3389/fgene.2021.695036

Chen DB , Xie XW , Zhao YJ , et al . RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A . Sci Rep 2020 ; 10 ( 1 ): 14538 . doi: 10.1038/s41598-020-71403-1 1001-9294-36-3-173/s41598-020-71403-1 . DOI: 10.1038/s41598-020-71403-1 http://doi.org/10.1038/s41598-020-71403-1

Huo J , Wu L , Zang Y . Construction and validation of a reliable six-gene prognostic signature based on the TP53 alteration for hepatocellular carcinoma . Front Oncol 2021 ; 11 : 618976 . doi: 10.3389/fonc.2021.618976 1001-9294-36-3-173/fonc.2021.618976 . DOI: 10.3389/fonc.2021.618976 http://doi.org/10.3389/fonc.2021.618976

Sun Y , Wu L , Zhong Y , et al . Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 2021 ; 184(2):404- 21 . e16 . doi: 10.1016/j.cell.2020.11.041 1001-9294-36-3-173/j.cell.2020.11.041 . DOI: 10.1016/j.cell.2020.11.041 http://doi.org/10.1016/j.cell.2020.11.041

Li N , Long Y , Fan X , et al . Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues . J Exp Clin Cancer Res 2009 ; 28 ( 1 ): 122 . doi: 10.1186/1756-9966-28-122 1001-9294-36-3-173/1756-9966-28-122 . DOI: 10.1186/1756-9966-28-122 http://doi.org/10.1186/1756-9966-28-122

Wei D , Zeng Y , Xing X , et al . Proteome differences between hepatitis B Virus genotype-B- and genotype-C-induced hepatocellular carcinoma revealed by iTRAQ-based quantitative proteomics . J Proteome Res 2016 ; 15 ( 2 ): 487 - 98 . doi: 10.1021/acs.jproteome.5b00838 1001-9294-36-3-173/acs.jproteome.5b00838 . DOI: 10.1021/acs.jproteome.5b00838 http://doi.org/10.1021/acs.jproteome.5b00838

Du Z , Liu X , Wei X , et al . Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma . Sci Rep 2020 ; 10 ( 1 ): 15552 . doi: 10.1038/s41598-020-72510-9 1001-9294-36-3-173/s41598-020-72510-9 . DOI: 10.1038/s41598-020-72510-9 http://doi.org/10.1038/s41598-020-72510-9

Gao Q , Zhu H , Dong L , et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 2019; 179(2) : 561- 77 . e22 . doi : 10.1016/j.cell.2019.08.052. Erratum in: Cell 2019 1001-9294-36-3-173/j.cell.2019.08.052. Erratum in: Cell 2019 ; 179(5):1240. doi 10.1016/j.cell.2019.10.038 1001-9294-36-3-173/j.cell.2019.10.038 . DOI: 10.1016/j.cell.2019.10.038 http://doi.org/10.1016/j.cell.2019.10.038

Zhang F , Wang Y , Chen G , et al . Growing human hepatocellular tumors undergo a global metabolic reprogramming . Cancers (Basel) 2021 ; 13 ( 8 ): 1980 . doi: 10.3390/cancers13081980 1001-9294-36-3-173/cancers13081980 . DOI: 10.3390/cancers13081980 http://doi.org/10.3390/cancers13081980

Lu S , Cai S , Peng X , et al . Integrative transcriptomic, proteomic and functional analysis reveals ATP1B3 as a diagnostic and potential therapeutic target in hepatocellular carcinoma . Front Immunol 2021 ; 12 : 636614 . doi: 10.3389/fimmu.2021.636614 1001-9294-36-3-173/fimmu.2021.636614 . DOI: 10.3389/fimmu.2021.636614 http://doi.org/10.3389/fimmu.2021.636614

Wang L , Zhang Z , Li Y , et al . Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma . Aging (Albany NY) 2020 ; 13 ( 2 ): 2480 - 505 . doi: 10.18632/aging.202281 1001-9294-36-3-173/aging.202281 . DOI: 10.18632/aging.202281 http://doi.org/10.18632/aging.202281

Segal E , Sirlin CB , Ooi C , et al . Decoding global gene expression programs in liver cancer by noninvasive imaging . Nat Biotechnol 2007 ; 25 ( 6 ): 675 - 80 . doi: 10.1038/nbt1306 1001-9294-36-3-173/nbt1306 . DOI: 10.1038/nbt1306 http://doi.org/10.1038/nbt1306

McCague C , Beer L . Radioproteomics in patients with ovarian cancer . Br J Radiol 2021 ; 94 ( 1125 ): 20201331 . doi: 10.1259/bjr.20201331 1001-9294-36-3-173/bjr.20201331 . DOI: 10.1259/bjr.20201331 http://doi.org/10.1259/bjr.20201331

Badic B , Tixier F , Cheze Le Rest C, et al. Radiogenomics in colorectal cancer . Cancers (Basel) 2021 ; 13 ( 5 ): 973 . doi: 10.3390/cancers13050973 1001-9294-36-3-173/cancers13050973 . DOI: 10.3390/cancers13050973 http://doi.org/10.3390/cancers13050973

Lo Gullo R , Daimiel I , Morris EA , et al . Combining molecular and imaging metrics in cancer: radiogenomics . Insights Imaging 2020 ; 11 ( 1 ): 1 . doi: 10.1186/s13244-019-0795-6 1001-9294-36-3-173/s13244-019-0795-6 . DOI: 10.1186/s13244-019-0795-6 http://doi.org/10.1186/s13244-019-0795-6

浏览量

887

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease

Topoisomerase Ⅱα Gene as a Marker for Prognostic Prediction of Hepatocellular Carcinoma: A Bioinformatics Analysis

Radiomics in Antineoplastic Agents Development: Application and Challenge in Response Evaluation

Research Progress in Targeted Therapy of Hepatocellular Carcinoma

Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An in vitro and in vivo Study